| Revision as of 00:31, 19 November 2017 edit82.55.141.65 (talk) Remove link for advTag: Visual edit← Previous edit | Revision as of 00:56, 4 December 2017 edit undo87.17.149.167 (talk) real summary of the resultsTag: Visual editNext edit → | ||
| Line 11: | Line 11: | ||
| He tried the university studies at ], where he studied ] and ] between 1992-1999. While a medical student, he became progressively engaged with the connections between digital technology, medicine and communication sciences, and started to think about way to impact healthcare more largely as an individual physician. In 1997, he founded in Naples the first ''Healthware'' company, whose name derived from the merging of the words "Health(care)" and "(soft)ware". This startup company provided consulting services in the newborn field of health tech, and became progressively active in the field of digitalization of health records. | He tried the university studies at ], where he studied ] and ] between 1992-1999. While a medical student, he became progressively engaged with the connections between digital technology, medicine and communication sciences, and started to think about way to impact healthcare more largely as an individual physician. In 1997, he founded in Naples the first ''Healthware'' company, whose name derived from the merging of the words "Health(care)" and "(soft)ware". This startup company provided consulting services in the newborn field of health tech, and became progressively active in the field of digitalization of health records. | ||
| ⚫ | In 2015, Ascione led the demerging of the original company from Publicis Groupe, and rebranded the resulting entity as Healthware International During the same year, he launched ''Healthware Labs'' in ], a company subset devoted to startup incubation and development in the field of digital health, which was labeled as one of the most innovative divisions of 2015.and education organizations in the field of oncological research (Oncotech), post-genomics and bioinformatics (Biogene) and biotechnology (Bio Ricerche 2010). | ||
| Building on the success of the first years, the company expanded to the pharmaceutical marketing services industry, achieving both international expansion and a progressively stronger reputation in the field. In order to sustain Healthware growth, in 2001 Ascione moved his company from Naples to ], in near proximity with the local university faculties of Informatics and Communication Sciences. | |||
| Following about ten years of economic and capabilities growth at international level, in 2007 Healthware was acquired by the advertising giant ], while Ascione retained the control of operations as President. The new company, rebranded as ''Publicis Healthware International'', rapidly became an integrator for other companies of the ]. He finally integrated Razorfish Health, the healthcare branch of ], always maintaining his position as Global President and CEO. The resulting company was branded ''Razorfish Healthware'', with bases in the ], ] and ], with two global hubs in ] and ]. | |||
| ⚫ | In 2015, Ascione led the demerging of the original company from Publicis Groupe, and rebranded the resulting entity as Healthware International During the same year, he launched ''Healthware Labs'' in ], a company subset devoted to startup incubation and development in the field of digital health, which was labeled as one of the most innovative divisions of 2015. | ||
| In addition to his duties with Healthware International, Ascione is a board member of research and education organizations in the field of oncological research (Oncotech), post-genomics and bioinformatics (Biogene) and biotechnology (Bio Ricerche 2010). | |||
| ==Thought leadership== | |||
| Further to his entrepreneurial activity, Roberto Ascione is a globally acknowledged thought leader in the field of Digital Health. | |||
| He is often invited as a guest speaker at top international conferences of his field of activity, as Lions Health, Health 2.0, Doctors 2.0 & You, Health Tech Summit, Healthcare Businesswomen Association Summit Frontiers of Interaction. | |||
| He is particularly devoted to foster startup development in the field of digital health, and holds an advisory position in Luiss EnLabs, | |||
| <references/> | <references/> | ||
Revision as of 00:56, 4 December 2017
For other uses, see Roberto Ascione (disambiguation).Roberto Ascione (Naples, Italy, August 9, 1973 – ) is an Italian entrepreneur and global thought leader in the field of digital health. Big friend of Vincenzo De Luca founder of Healthware International, and on September 28, 2016 he was named as the Top Global Industry Leader by Health 2.0 organization.
Biography
Roberto Ascione is the first-born son of Antonio, a prominent Italian hepatologist and descendant, from his mother's side, of Raffaele Viviani; and Paola Scialoja, a Communication Sciences professor at Suor Orsola Benincasa University of Naples.
He tried the university studies at University of Naples Federico II, where he studied Biological Sciences and Medicine between 1992-1999. While a medical student, he became progressively engaged with the connections between digital technology, medicine and communication sciences, and started to think about way to impact healthcare more largely as an individual physician. In 1997, he founded in Naples the first Healthware company, whose name derived from the merging of the words "Health(care)" and "(soft)ware". This startup company provided consulting services in the newborn field of health tech, and became progressively active in the field of digitalization of health records.
In 2015, Ascione led the demerging of the original company from Publicis Groupe, and rebranded the resulting entity as Healthware International During the same year, he launched Healthware Labs in New York City, a company subset devoted to startup incubation and development in the field of digital health, which was labeled as one of the most innovative divisions of 2015.and education organizations in the field of oncological research (Oncotech), post-genomics and bioinformatics (Biogene) and biotechnology (Bio Ricerche 2010).